Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
3 hedge funds and large institutions have $27.8K invested in Immunogen Inc in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 322 closing their positions.
99% less funds holding
Funds holding: 327 → 3 (-324)
100% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 322
100% less funds holding in top 10
Funds holding in top 10: 35 → 0 (-35)
100% less capital invested
Capital invested by funds: $7.66B → $27.8K (-$7.66B)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Mather Group
Chicago,
Illinois
|
+$1.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$755M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$704M |
| 3 |
BlackRock
New York
|
-$647M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$487M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$327M |
IMGN Hedge Fund Activity: Q1 2024 in Review
3 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2024, worth a combined $27.8K — down 100% from $7.66B a quarter earlier.
Sellers outnumbered buyers: 322 funds closed out of IMGN and 1 opened new positions — a net loss of 321 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Mather Group, opening a new position worth an estimated $1.84K. The largest seller was Vanguard Group, exiting entirely with an estimated $755M sold.
- 3 institutional investors held Immunogen Inc (IMGN) as of Q1 2024, down from 327 in Q4 2023.
- Funds reported $27.8K of Immunogen Inc stock for Q1 2024, down 100% quarter-over-quarter.
- 1 fund opened new Immunogen Inc positions in Q1 2024 and 322 closed out, a net change of -321 holders.
- The largest Immunogen Inc buyer in Q1 2024 was Mather Group, an estimated $1.84K added.
- The largest Immunogen Inc seller in Q1 2024 was Vanguard Group, an estimated $755M sold.
Based on aggregated 13F filings for Q1 2024.